DNA甲基化与2型糖尿病:使用孟德尔随机化来评估因果关系。

IF 16.4 1区 化学 Q1 CHEMISTRY, MULTIDISCIPLINARY
Accounts of Chemical Research Pub Date : 2019-12-01 Epub Date: 2019-11-15 DOI:10.1007/s40142-019-00176-5
Diana L Juvinao-Quintero, Marie-France Hivert, Gemma C Sharp, Caroline L Relton, Hannah R Elliott
{"title":"DNA甲基化与2型糖尿病:使用孟德尔随机化来评估因果关系。","authors":"Diana L Juvinao-Quintero,&nbsp;Marie-France Hivert,&nbsp;Gemma C Sharp,&nbsp;Caroline L Relton,&nbsp;Hannah R Elliott","doi":"10.1007/s40142-019-00176-5","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose of review: </strong>This review summarises recent advances in the field of epigenetics in order to understand the aetiology of type 2 diabetes (T2D).</p><p><strong>Recent findings: </strong>DNA methylation at a number of loci has been shown to be robustly associated with T2D, including <i>TXNIP, ABCG1, CPT1A</i>, and <i>SREBF1</i>. However, due to the cross-sectional nature of many epidemiological studies and predominant analysis in samples derived from blood rather than disease relevant tissues, inferring causality is difficult. We therefore outline the use of Mendelian randomisation (MR) as one method able to assess causality in epigenetic studies of T2D.</p><p><strong>Summary: </strong>Epidemiological studies have been fruitful in identifying epigenetic markers of T2D. Triangulation of evidence including utilisation of MR is essential to delineate causal from non-causal biomarkers of disease. Understanding the causality of epigenetic markers in T2D more fully will aid prioritisation of CpG sites as early biomarkers to detect disease or in drug development to target epigenetic mechanisms in order to treat patients.</p>","PeriodicalId":1,"journal":{"name":"Accounts of Chemical Research","volume":null,"pages":null},"PeriodicalIF":16.4000,"publicationDate":"2019-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1007/s40142-019-00176-5","citationCount":"6","resultStr":"{\"title\":\"DNA Methylation and Type 2 Diabetes: the Use of Mendelian Randomization to Assess Causality.\",\"authors\":\"Diana L Juvinao-Quintero,&nbsp;Marie-France Hivert,&nbsp;Gemma C Sharp,&nbsp;Caroline L Relton,&nbsp;Hannah R Elliott\",\"doi\":\"10.1007/s40142-019-00176-5\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Purpose of review: </strong>This review summarises recent advances in the field of epigenetics in order to understand the aetiology of type 2 diabetes (T2D).</p><p><strong>Recent findings: </strong>DNA methylation at a number of loci has been shown to be robustly associated with T2D, including <i>TXNIP, ABCG1, CPT1A</i>, and <i>SREBF1</i>. However, due to the cross-sectional nature of many epidemiological studies and predominant analysis in samples derived from blood rather than disease relevant tissues, inferring causality is difficult. We therefore outline the use of Mendelian randomisation (MR) as one method able to assess causality in epigenetic studies of T2D.</p><p><strong>Summary: </strong>Epidemiological studies have been fruitful in identifying epigenetic markers of T2D. Triangulation of evidence including utilisation of MR is essential to delineate causal from non-causal biomarkers of disease. Understanding the causality of epigenetic markers in T2D more fully will aid prioritisation of CpG sites as early biomarkers to detect disease or in drug development to target epigenetic mechanisms in order to treat patients.</p>\",\"PeriodicalId\":1,\"journal\":{\"name\":\"Accounts of Chemical Research\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":16.4000,\"publicationDate\":\"2019-12-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1007/s40142-019-00176-5\",\"citationCount\":\"6\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Accounts of Chemical Research\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1007/s40142-019-00176-5\",\"RegionNum\":1,\"RegionCategory\":\"化学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2019/11/15 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q1\",\"JCRName\":\"CHEMISTRY, MULTIDISCIPLINARY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Accounts of Chemical Research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1007/s40142-019-00176-5","RegionNum":1,"RegionCategory":"化学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2019/11/15 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"CHEMISTRY, MULTIDISCIPLINARY","Score":null,"Total":0}
引用次数: 6

摘要

综述目的:本文综述了近年来表观遗传学领域的研究进展,以了解2型糖尿病(T2D)的病因。最近的研究发现:DNA甲基化在许多位点被证明与T2D密切相关,包括TXNIP、ABCG1、CPT1A和SREBF1。然而,由于许多流行病学研究的横断面性质和主要分析来自血液而不是疾病相关组织的样本,推断因果关系是困难的。因此,我们概述了孟德尔随机化(MR)作为一种能够评估T2D表观遗传学研究因果关系的方法。流行病学研究在识别T2D的表观遗传标记方面取得了丰硕成果。包括磁共振成像在内的证据三角测量对于区分疾病的因果性和非因果性生物标志物至关重要。更全面地了解T2D中表观遗传标记的因果关系将有助于优先选择CpG位点作为早期生物标记物来检测疾病或在药物开发中针对表观遗传机制来治疗患者。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

DNA Methylation and Type 2 Diabetes: the Use of Mendelian Randomization to Assess Causality.

DNA Methylation and Type 2 Diabetes: the Use of Mendelian Randomization to Assess Causality.

Purpose of review: This review summarises recent advances in the field of epigenetics in order to understand the aetiology of type 2 diabetes (T2D).

Recent findings: DNA methylation at a number of loci has been shown to be robustly associated with T2D, including TXNIP, ABCG1, CPT1A, and SREBF1. However, due to the cross-sectional nature of many epidemiological studies and predominant analysis in samples derived from blood rather than disease relevant tissues, inferring causality is difficult. We therefore outline the use of Mendelian randomisation (MR) as one method able to assess causality in epigenetic studies of T2D.

Summary: Epidemiological studies have been fruitful in identifying epigenetic markers of T2D. Triangulation of evidence including utilisation of MR is essential to delineate causal from non-causal biomarkers of disease. Understanding the causality of epigenetic markers in T2D more fully will aid prioritisation of CpG sites as early biomarkers to detect disease or in drug development to target epigenetic mechanisms in order to treat patients.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Accounts of Chemical Research
Accounts of Chemical Research 化学-化学综合
CiteScore
31.40
自引率
1.10%
发文量
312
审稿时长
2 months
期刊介绍: Accounts of Chemical Research presents short, concise and critical articles offering easy-to-read overviews of basic research and applications in all areas of chemistry and biochemistry. These short reviews focus on research from the author’s own laboratory and are designed to teach the reader about a research project. In addition, Accounts of Chemical Research publishes commentaries that give an informed opinion on a current research problem. Special Issues online are devoted to a single topic of unusual activity and significance. Accounts of Chemical Research replaces the traditional article abstract with an article "Conspectus." These entries synopsize the research affording the reader a closer look at the content and significance of an article. Through this provision of a more detailed description of the article contents, the Conspectus enhances the article's discoverability by search engines and the exposure for the research.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信